Press release
Pancreaze (Pancrelipase) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share
Pancreaze (Pancrelipase) Market Size
The market for pancreaze (pancrelipase) has seen substantial expansion in the past years. The expected growth is from $1566.86 million in 2024 to $1660.16 million in 2025, with a compound annual growth rate (CAGR) of 6.0%. The historical growth can be traced back to factors such as the increasing occurrence of exocrine pancreatic insufficiency (epi), a growing elderly population, enhanced treatment methods, a surge in cases of pancreatic cancer, and the international progression of healthcare services.
A significant increase is expected in the pancreaze (pancrelipase) market size in the upcoming years, with its value projected to reach $2063.36 million in 2029 with a CAGR of 5.6%. This assumed growth in the forecast period can be credited to the escalating incidence of diseases of the pancreas, continuous research and clinical tests, enhanced access to global healthcare, development of healthcare infrastructure, and government-driven initiatives and refund policies. Key trends for the forecast period encompass improvements in enzyme delivery systems, technological progress, the merging of digital health solutions, a rise in partnerships, and the creation of enteric-coated formulations.
What Is Driving the Growth Trajectory of the Pancreaze (Pancrelipase) Market?
The surge in cystic fibrosis cases is anticipated to accelerate the expansion of the pancreaze (pancrelipase) market. The digestive system, lungs, and other organs are affected by this genetic disorder, which initiates the creation of thick, sticky mucus that precipitates blockages, infections, and dysfunctional operation. The escalation in cystic fibrosis instances is primarily attributed to enhanced awareness, refined diagnostic methods, and broadened genetic testing programs. These measures help in uncovering more cases, encompassing milder forms that were previously undetected. Pancreaze (pancrelipase) is utilized in cystic fibrosis to supplement digestion by substituting the enzymes that the pancreas is unable to generate effectively. This aids patients in nutrient absorption from food, thereby ameliorating their overall nutritional health. For example, the Cystic Fibrosis Trust, a British charity that caters to people suffering from cystic fibrosis, reported in October 2024 that patient registrations increased by 1.5% year-over-year from 11,148 in 2022 to 11,318 in 2023. Thus, the upsurge in cystic fibrosis cases is propelling the growth of the pancreaze (pancrelipase) market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20173&type=smp
Which Leading Companies Are Shaping the Growth of the Pancreaze (Pancrelipase) Market?
Major companies operating in the pancreaze (pancrelipase) market include AbbVie Inc.
What Are the Latest Innovations in the Pancreaze (Pancrelipase) Market?
The pancreaze (pancrelipase) market is trending toward greater reliance on clinical evidence, particularly clinical trial data, to prove the effectiveness of drugs. Such data are pivotal in expediting the regulatory approval process, improving patient results, and reinforcing a drug's market standing. For instance, in May 2024, Vivus, Inc., an American biopharmaceutical company, revealed new clinical trial data demonstrating the effectiveness of PANCREAZE (pancrelipase) in maintaining weight among patients with pancreatic ductal adenocarcinoma (PDAC) who were undergoing chemotherapy and suffering from cachexia and exocrine pancreatic insufficiency (EPI). The data also show the potential advantages of PANCREAZE in decreasing stool frequency and improving stool consistency. Researchers at Cedars-Sinai Medical Center and the Samuel Oschin Cancer Center executed the study as an investigator-led trial.
What Are the Key Segments of the Pancreaze (Pancrelipase) Market?
The pancreaze (pancrelipase) market covered in this report is segmented -
1) By Type: Capsule, Tablet
2) By Age: Children, Adults, Geriatrics
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Chronic Pancreatitis, Cystic Fibrosis, Other Applications
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pancreaze-pancrelipase-global-market-report
Which Region Dominates the Pancreaze (Pancrelipase) Market?
North America was the largest region in the pancreaze (pancrelipase) market in 2024. The regions covered in the pancreaze (pancrelipase) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Pancreaze (Pancrelipase) Global Market Report?
- Market Size Analysis: Analyze the pancreaze (pancrelipase) Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the pancreaze (pancrelipase) market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall pancreaze (pancrelipase) market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the pancreaze (pancrelipase) market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20173
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pancreaze (Pancrelipase) Market Outlook 2025-2034: Key Trends, Growth Drivers, and Market Share here
News-ID: 3872941 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Pancreaze
Cystic Fibrosis Prevalence Surge Fuels Demand For Pancreaze (Pancrelipase) Treat …
The Pancreaze (Pancrelipase) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Pancreaze (Pancrelipase) Market?
The market for pancreaze (pancrelipase) has seen robust growth in recent times. The market size is anticipated to escalate from $1566.86 million in 2024 to…
Exocrine Pancreatic Insufficiency Market Size is anticipated to grow by 2034, es …
DelveInsight's "Exocrine Pancreatic Insufficiency Market Insight, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of exocrine pancreatic insufficiency, historical and forecasted epidemiology as well as the exocrine pancreatic insufficiency market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Explore the intricate details of the Exocrine Pancreatic Insufficiency Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive…
Global Sales of Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnos …
𝐄𝐱𝐨𝐜𝐫𝐢𝐧𝐞 𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐭𝐢𝐜 𝐢𝐧𝐬𝐮𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲 (𝐄𝐏𝐈) 𝐭𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐚𝐧𝐝 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 to reach US$ 7.3 Bn by 2027, it is anticipated to expand at a CAGR of 7.2% from 2019 to 2027.
According to Transparency Market Research's latest report on the global exocrine pancreatic insufficiency (EPI) therapeutics & diagnostics market for the historical period 2017-2018 and forecast period 2019-2027, rise in prevalence of cystic fibrosis and chronic pancreatitis to escalate the growth of global exocrine pancreatic insufficiency (EPI)…
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Mark …
Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market research report comprises of fundamental, secondary and advanced information related to the global status and trend, market size, sales volume, market share, growth, future trends analysis, segment and forecasts from 2019 – 2026. The report also encompasses market overview, premium insights, key insights and company profiles in detail of the key market players. Transparent, reliable and extensive market information of this Exocrine…
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Mark …
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market report is the best to know the trends and opportunities in industry. The forecast, analysis, evaluations and estimations carried out in this Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics report are all based upon the well-established tools and techniques such as SWOT analysis and Porter’s Five Forces analysis. These are the authentic tools used in market analysis on which businesses can…
Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Mark …
The Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market report contains market insights and analysis for ABC industry which are backed up by SWOT analysis. In this report, several aspects about the market research and analysis for the ABC industry have been underlined. This market research report acts as a great support to any size of business whether it is large, medium or small. The precise and state-of-the-art information…
